Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reverse transcriptase inhibitors in plaque psoriasis
2019-002236-91Phase 2Completed
- Sponsor
- CHU Nîmes
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of emtricitabine + tenofovir disoproxil in plaque psoriasis, sponsored by CHU Nîmes. Primary endpoint: Detection of RNA:DNA duplexes. Started Jan 2020; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2019-002236-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002236-91.